TEMPEST THERAPEUTICS INC (TPST)
US87978U1088 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 280K | 650K 132.14% | 300K -53.85% | 33.997K -100.00% | 25.806M | 120.05M 365.20% | 229.81M 91.43% | 431.87M 87.92% | ||||||||||
| EBITDA YoY % growth | -70.71M -48.93% | -73.37M -3.76% | -44.93M 38.76% | N/A 40.26% | -46.816M -68.78% | -36.555M 20.93% | -28.356M 25.68% | -36.72M -27.72% | -30.192M 15.36% | -36.516M -26.90% | -43.86M -20.11% | -55.08M -25.58% | -63.444M -15.19% | -78.438M -23.63% | N/A | N/A | N/A | |
| EBIT YoY % growth | -72M -50.22% | -75.61M -5.01% | -46.58M 38.39% | -32.667M 42.31% | -46.064M -68.96% | -36.223M 20.77% | -28.374M 24.97% | -35.979M -28.34% | -29.366M 15.83% | -38.07M -30.57% | -46.469M -22.06% | -61.449M -32.24% | -73.158M -19.06% | -65.178M 10.91% | -3.57M 94.52% | 73.746M 2,165.71% | 215.73M 192.53% | |
| Operating Margin | -25,714.29% | -11,632.31% | -15,526.67% | -96,089.62% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -252.57% | -2.97% | 32.09% | 49.95% | |
| EPS YoY % growth | -609.75 -25.46% | -551.25 9.59% | -312.75 43.27% | -38.10 87.82% | -48.76 -28.36% | -28.76 40.49% | -6.54 43.09% | -3.32 80.31% | -1.97 40.18% | -1.42 27.09% | -1.06 25.44% | -1.31 -23.41% | -1.57 -19.82% | -0.99 36.55% | -0.06 93.85% | 1.18 2,033.33% | 3.16 167.24% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 27.53% | -0.29 20.67% | -0.31 25.93% | -0.33 19.15% | -0.36 -31.48% | -0.49 -71.43% | -0.55 -77.05% | -0.56 -69.23% | -0.56 -54.93% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | -7.854M -10.11% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.346M -37.68% | -10.71M -34.31% | -11.475M -19.76% | -11.73M -11.17% | -12.495M -20.78% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.41 14.58% | -0.37 | -0.04 | -11.04% |
| Q2 2024 Q2Q % growth | -0.42 22.22% | -0.41 | -0.01 | -2.17% |
| Q1 2024 Q2Q % growth | -0.36 34.55% | -0.38 | 0.02 | 5.68% |
| Q4 2023 Q2Q % growth | -0.38 39.68% | -0.39 | 0.01 | 3.43% |
| Q3 2023 Q2Q % growth | -0.48 27.27% | -0.58 | 0.10 | 17.84% |
| Q2 2023 Q2Q % growth | -0.54 31.65% | -0.53 | -0.01 | -2.30% |
| Q1 2023 Q2Q % growth | -0.55 53.39% | -0.66 | 0.11 | 16.04% |
| Q4 2022 Q2Q % growth | -0.63 43.78% | -0.77 | 0.14 | 18.62% |
| Q3 2022 Q2Q % growth | -0.66 45.45% | -0.82 | 0.16 | 19.37% |
| Q2 2022 Q2Q % growth | -0.79 89.65% | -0.94 | 0.15 | 16.12% |
| Q1 2022 Q2Q % growth | -1.18 82.12% | -1.14 | -0.04 | -3.60% |
| Q4 2021 Q2Q % growth | -1.12 80.85% | -1.26 | 0.14 | 10.93% |
| Q3 2021 Q2Q % growth | -1.21 76.27% | -1.07 | -0.14 | -13.34% |
| Q2 2021 Q2Q % growth | -7.63 9.17% | -0.89 | -6.74 | -754.90% |
| Q1 2021 Q2Q % growth | -6.60 32.31% | -5.36 | -1.24 | -23.25% |
| Q4 2020 Q2Q % growth | -5.85 55.17% | -5.25 | -0.60 | -11.37% |
| Q3 2020 Q2Q % growth | -5.10 60.92% | -7.04 | 1.94 | 27.54% |
| Q2 2020 Q2Q % growth | -8.40 24.32% | -8.36 | -0.04 | -0.43% |
| Q1 2020 Q2Q % growth | -9.75 16.67% | -10.20 | 0.45 | 4.41% |
| Q4 2019 Q2Q % growth | -13.05 | -12.42 | -0.63 | -5.08% |
| Q3 2019 Q2Q % growth | -13.05 | -12.63 | -0.42 | -3.31% |
| Q2 2019 Q2Q % growth | -11.10 | -12.36 | 1.26 | 10.21% |
| Q1 2019 Q2Q % growth | -11.70 | -10.76 | -0.94 | -8.73% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 24.37% | 0% | 8.1% |
| Revenue | N/A | N/A | N/A | N/A |